** Shares of Glenmark Pharmaceuticals GLEN.NS up ~4% to 1350.5 rupees

** Co settles remaining antitrust and consumer protection lawsuits with three plaintiffs in connection with generic cholesterol drug Zetia

** Plaintiffs include Humana HUM.N, Centene Corp CNC.N

and Kaiser Foundation Health Plan [RIC:RIC:KISERF.UL]

** Under terms of $7 mln settlement, Glenmark denies allegations by plaintiffs, concedes no liability

** Including session's gains, GLEN shares up 48.3% in the last 12 months

(Reporting by Ananta Agarwal in Bengaluru)

((Ananta.Agarwal@thomsonreuters.com))